SCHEMBL13044589

SCHEMBL13044589

CCOC(=O)C(c1ccc(C)nc1)N1CCN(C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 3/20 0.42
SLC1A3 P43003 2/20 0.39
SLC1A1 P43005 2/20 0.39
KCNH2 Q12809 1/20 0.39
CYP2C9 P11712 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ADORA2A P29274 1/20 0.37
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
MC4R P32245 1/20 0.37
GAA P10253 3/20 0.37
TP53 P04637 1/20 0.37
MAPK10 P53779 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3638763 0.84 SLC1A2 (0.46) SLC1A2SLC1A3SLC1A1KCNH2MEN1
SCHEMBL6640205 0.84 SLC1A2 (0.60) SLC1A2SLC1A3SLC1A1KCNH2MEN1
SCHEMBL13044694 0.79 GHSR (0.43) MEN1KMT2AALDH1A1OPRD1KDM4E
SCHEMBL13044650 0.77 MC4R (0.42) KCNH2CYP2C9OPRD1OPRK1MC4R
SCHEMBL29761956 0.77 SLC1A2 (0.58) SLC1A2SLC1A3SLC1A1KCNH2ALDH1A1
SCHEMBL13044558 0.76 NAMPT (0.41)
SCHEMBL13044576 0.76 MC4R (0.46) MEN1KMT2ANPSR1MC4R
SCHEMBL13044658 0.74 GAA (0.52) SLC1A3KCNH2MEN1KMT2AALDH1A1
SCHEMBL30441395 0.74 MMP8 (0.44) CYP2C9MEN1KMT2AALDH1A1LMNA
SCHEMBL16286568 0.74 MMP8 (0.44) CYP2C9MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R SLC1A2 1370/4885SLC1A3 814/4885SLC1A1 825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.